Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Seropositive umbilical cord blood transplant (UCBT) recipients are at increased risk for CMV complications. To reduce CMV complications, we adopted an intensive strategy that consisted of ganciclovir administered before transplantation (5 mg/kg intravenously daily from day −8 to day −2), high-dose a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Milano, Filippo, Pergam, Steven A., Xie, Hu, Leisenring, Wendy M., Gutman, Jonathan A., Riffkin, Ivy, Chow, Victor, Boeckh, Michael J., Delaney, Colleen
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2011
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3217367/
https://ncbi.nlm.nih.gov/pubmed/21937692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-06-361618
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky